5304-59-6

Basic information

• Product Name: 1-(4-chlorophenyl)biguanide
• Synonyms: 1-(4-chlorophenyl)biguanide;4-chlorophenylbiguanide;1-(p-Chlorophenyl)biguanide;Ai3-52174;Einecs 226-155-6;Nsc 220325;1-(4-Chlorophenyl)biguanide-d4 Hydrochloride;1-(p-Chlorophenyl)biguanide-d4 Monohydrochloride
• CAS NO: 5304-59-6
• Molecular Formula: C₈H₁₀ClN₅
• Molecular Weight: 211.6515
• EINECS: 226-155-6
• Mol File: 5304-59-6.mol
• Article Data: 4

Chemical Properties

• Melting Point: 144 °C
• Boiling Point: 426.4°Cat760mmHg
• Flash Point: 211.7°C
• Appearance: /
• Density: 1.49g/cm³
• PKA: 11.39±0.10(Predicted)
• CAS DataBase Reference: 1-(4-chlorophenyl)biguanide(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-chlorophenyl)biguanide(5304-59-6)
• EPA Substance Registry System: 1-(4-chlorophenyl)biguanide(5304-59-6)

Safety Data

• Hazardous Substances Data: 5304-59-6(Hazardous Substances Data)

Usage

Uses

Labelled 1-(4-Chlorophenyl)biguanide (C378540). 1-(4-Chlorophenyl)biguanide is a guanide derivative that can inhibit significantly dihydrofolate reductase (DHFR).

InChI:InChI=1/C8H10ClN5/c9-5-1-3-6(4-2-5)13-8(12)14-7(10)11/h1-4H,(H6,10,11,12,13,14)

Upstream product

• 20265-96-7 p-chloroaniline hydrochloride 
• 127099-85-8 N-Cyanoguanidine 
• 102-02-3 1-phenylbiguanide 
• 106-47-8 4-chloro-aniline 

Downstream Products

• 102467-63-0 1-(6-bromo-quinazolin-4-yl)-5-(4-chloro-phenyl)-biguanide 
• 102893-49-2 N-(4-chloro-phenyl)-N'-(4-oxo-2,6-diphenyl-4H-pyridine-1-carboximidoyl)-guanidine 
• 30805-24-4 1-(4-chloro-phenyl)-6-methyl-1,6-dihydro-[1,3,5]triazine-2,4-diamine 
• 23948-47-2 N-(4-chloro-phenyl)-N'-(4,5-dimethyl-6-oxo-1,6-dihydro-pyrimidin-2-yl)-guanidine 
• 500-42-5 chlorazanil 
• 111474-64-7 1-(4-chloro-phenyl)-6-hexyl-1,6-dihydro-[1,3,5]triazine-2,4-diyldiamine; hydrochloride 
• 30360-18-0 N,N'-bis(4-chlorophenyl)melamine 
• 1482-62-8 1-(4-chlorophenyl)-3-cyanoguanidine 
• 58247-24-8 1-(4-chlorophenyl)-3-amidinourea 
• 51594-52-6 N¹-p-Chlor-phenyl-N⁵-acetoacetylbiguanid 
• 96583-15-2 N-(4-chloro-phenyl)-6-(5-nitro-furan-2-yl)-[1,3,5]triazine-2,4-diamine 
• 110045-63-1 N-(4-chlorophenyl)-N'-<4,6-bis(trichloromethyl)-1,3,5-triazin-2-yl>imidodicarbonimidic diamide 
• 88406-62-6 N-{[N'-(4-Chloro-phenyl)-guanidino]-imino-methyl}-2-[2-[N'-(4-chloro-phenyl)-guanidino]-5-oxo-3,5-dihydro-imidazol-(4Z)-ylidene]-acetamide 

Relevant articles and documents

NOVEL CYCLIC GMP-AMP SYNTHASE (CGAS) INHIBITORS AND THEIR METHOD OF USE

Methods of treating diseases related to cGAS activation. Small molecule inhibitors of cGAS and pharmaceutical compositions and uses thereof in treating autoimmune diseases or inflammation.

Novel compounds having treatment of immune diseases and use therof

The present invention relates to a novel compound capable of effectively treating and preventing immune disease and to a use thereof. The novel compound of the present invention suppresses the production of inflammatory cytokines and increases activities of regulatory T cells having immune regulatory ability. In addition, the compound of the present invention controls over an excessive immune response by inhibiting the production of autoantibodies and differentiation of osteoclasts, thereby being able to be used for treating immune diseases induced by regulatory anomalies of various immune response such as autoimmune disease, inflammatory diseases, and transplant rejection.(a) Cell toxicity effect control(MTT assay)(AA) Normal mouse cell(b) Autoantibody production immune reaction control(c) Inflammatory cytokine production control(d) Inflammatory gene expression controlCOPYRIGHT KIPO 2016